Clinical Trial Update: Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 study comparing sevelamer carbonate powder to sevelamer hydrochloride tablets in chronic kidney disease patients on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Renagel (sevelamer)
• Renvela (sevelamer carbonate)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Kidney Diseases, Chronic Renal Insufficiency | Phase 3 | Status: COMPLETED